Evoke Pharma Inc reports results for the quarter ended in December - Earnings Summary

Evoke Pharma

08/03/2022 22:02

* Evoke Pharma Inc  EVOK.OQ  reported a quarterly adjusted
loss
of 6 cents​​ per share for the quarter ended in December. The
lone analyst forecast for the quarter was for a loss of 8 cents
per share.
    * Revenue rose 1,463.9% to $360.00 thousand from a year
ago; 
analysts expected $507.00 thousand. 
    * Evoke Pharma Inc's reported EPS for the quarter was a loss
of 6
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Evoke Pharma Inc shares had risen by 9.1% this quarter.
    * The company reported a quarterly loss of $1.67 million.
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 8 at 10:02 p.m.  ​All
figures in US dollars unless otherwise stated